Investor Relations

Corporate Profile

Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis – Tablo®. We believe the Tablo Hemodialysis System (Tablo), represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. We designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.

Stock Performance

Price

Change

Data Provided by Refinitiv. Minimum 15 minutes delayed.